NCT06756906 Comparison of High Flow Nasal Oxygen and Nasal Cannula in Burn Patients Under Sedation
| NCT ID | NCT06756906 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara City Hospital Bilkent |
| Condition | Burn Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-07-15 |
| Primary Completion | 2025-01-27 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2024-07-15 with a primary completion date of 2025-01-27.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Burn-related pain is severe and often difficult to manage. Burn patients often require high doses of opioids and anxiolytics. Anesthetic agents used during sedation such as benzodiazepines, propofol and opioids can cause respiratory depression, predisposing patients to hypoventilation and hypoxemia due to airway obstruction. Oxygen is administered to patients with a standard nasal cannula during sedation. High Flow Nasal Oxygen (HFNO) helps to improve the oxygenation of patients with respiratory distress by delivering high flow humidified oxygen through the nasal cannula at a high rate of up to 40-70 liters per minute. The aim of this study was to compare the effects of HFNO and nasal oxygen therapy in preventing hypoxemia in deeply sedated burn patients.
Eligibility Criteria
Inclusion Criteria : Voluntary patients over 18 years of age -ASA(American Society of Anaesthesiologists) I-III risk scores Exlusion Criteria Exclusion Criteria: * Intubation * Tracheostomies * Need for oxygen therapy due to preexisting disease * Pregnancy
Contact & Investigator
Ezgi Erkılıç, Assoc Prof
PRINCIPAL INVESTIGATOR
Ankara Bilkent City Hospital, Department of Anesthesiology
Frequently Asked Questions
Who can join the NCT06756906 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Burn Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06756906 currently recruiting?
Yes, NCT06756906 is actively recruiting participants. Contact the research team at dmrhnsmyy@gmail.com for enrollment information.
Where is the NCT06756906 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06756906 clinical trial?
NCT06756906 is sponsored by Ankara City Hospital Bilkent. The principal investigator is Ezgi Erkılıç, Assoc Prof at Ankara Bilkent City Hospital, Department of Anesthesiology. The trial plans to enroll 70 participants.